Reagent Validation to Facilitate Experimental Reproducibility

Abstract

Many results reported in the biomedical research literature cannot be independently reproduced, undermining the basic foundations of science. This overview is intended for researchers who are committed to improving the quality and integrity of biomedical science by raising awareness of both the sources of irreproducibility, and activities specifically targeted to address the issue. The irreproducibility of biomedical research is due to a variety of factors, known and unknown, that markedly influence experimental outcomes. Among the known factors are inadequate training or mentoring, or experimenter incompetence. These may result in flawed experimental design and execution that reflect a lack of planning, leading to an underpowering of a study, an absence of appropriate controls, selective data analysis, inappropriate statistical analysis, and/or investigator bias or fraud. Another frequently overlooked source of irreproducibility is failure to ensure that the equipment used is performing up to manufacturer specifications. Failure to validate/authenticate the experimental reagents is another source of irreproducibility. These include compounds, cell lines, antibodies, and the animal models used in a study. This overview discusses how a lack of validation of research reagents negatively impact experimental reproducibility, and provides guidelines to avoid these pitfalls. © 2018 by John Wiley & Sons, Inc.

Improving target assessment in biomedical research: the GOT-IT recommendations

“…In addition, a major requirement to ensure robust research outcomes is that researchers routinely question reagent purity, authenticate cell lines, validate antibodies and animal models, and include appropriate controls when planning and conducting an experiment 63 .…”

From spreadsheet lab data templates to knowledge graphs: A FAIR data journey in the domain of AMR research

“…Additionally, experimental data requires the preparation of a medium for growth for cultures. Previously, reports for discrepancies in the reproducibility of results due to vendor issues have been raised 37,38 . To avoid such discrepancies, purchases made by vendor-dedicated sites such as growth mediums were mapped to their respective vendor catalog identifiers, for instance, SIGMA (https://www.sigmaaldrich.com/), for growth medium and ATCC (https://www.atcc.org/), for non-clinical bacterial cultures.…”